Trial Profile
Validation of a Urine Assay to Measure Tenofovir Levels in Patients Taking Tenofovir Alafenamide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 26 Jun 2018 Status changed from active, no longer recruiting to completed.
- 03 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 24 Nov 2017 New trial record